Skip to main content

Articles

Page 2 of 14

  1. Injection drug use is on the rise in the USA, and skin and soft tissue infections (SSTI) are a common complication, resulting in significant morbidity and mortality. Due to structural barriers to care-seeking,...

    Authors: Andrew R. Gilbert, Julia L. Hellman, Michael S. Wilkes, Vaughan W. Rees and Phillip J. Summers

    Citation: Harm Reduction Journal 2019 16:69

    Content type: Research

    Published on:

  2. Chronic HCV infection causes substantial morbidity and mortality and, in co-infection with HIV, may result in immunological and virological failure following antiretroviral treatment. Estimates of HCV infectio...

    Authors: Germana Henry Leyna, Neema Makyao, Alexander Mwijage, Angela Ramadhan, Samuel Likindikoki, Mucho Mizinduko, Melkizedeck Thomas Leshabari, Kåre Moen and Elia John Mmbaga

    Citation: Harm Reduction Journal 2019 16:68

    Content type: Research

    Published on:

  4. Overdose education and naloxone distribution programs decrease opioid overdose deaths. However, no studies of such programs have been carried out in Denmark. The aim of this study was to evaluate the feasibili...

    Authors: Birgitte Thylstrup, Morten Hesse, Marian Jørgensen and Henrik Thiesen

    Citation: Harm Reduction Journal 2019 16:66

    Content type: Research

    Published on:

  7. Psychedelic microdosing is the trending practice of using tiny repeated doses of psychedelic substances to facilitate a range of supposed benefits. With only a few published studies to date, the subject is sti...

    Authors: Martin Andersson and Anette Kjellgren

    Citation: Harm Reduction Journal 2019 16:63

    Content type: Research

    Published on:

  8. Snus is an oral smokeless tobacco product which is usually placed behind the upper lip, either in a loose form or in portioned sachets, and is primarily used in Sweden and Norway. The purpose of this review is...

    Authors: Elizabeth Clarke, Keith Thompson, Sarah Weaver, Joseph Thompson and Grant O’Connell

    Citation: Harm Reduction Journal 2019 16:62

    Content type: Review

    Published on:

  9. In the context of the current US opioid crisis, people who inject drugs (PWID) are increasingly researched, but their ability to tell their own stories may be limited. Photovoice is a participatory action rese...

    Authors: Mari-Lynn Drainoni, Ellen Childs, Katie B. Biello, Dea L. Biancarelli, Alberto Edeza, Peter Salhaney, Matthew J. Mimiaga and Angela R. Bazzi

    Citation: Harm Reduction Journal 2019 16:61

    Content type: Research

    Published on:

  10. Venous access is a priority for people who inject drugs (PWID). Damage and scarring of peripheral veins can exacerbate health harms, such as skin and soft tissue infections (SSTI), and promote transitions to f...

    Authors: Magdalena Harris, Jenny Scott, Talen Wright, Rachel Brathwaite, Daniel Ciccarone and Vivian Hope

    Citation: Harm Reduction Journal 2019 16:60

    Content type: Research

    Published on:

  11. JUUL is the fastest growing and highest selling brand of e-cigarette/vapor products in the USA. Assessing the effect of JUUL vapor products on adult smokers’ use of conventional tobacco cigarettes can help inf...

    Authors: Christopher Russell, Farhana Haseen and Neil McKeganey

    Citation: Harm Reduction Journal 2019 16:59

    Content type: Research

    Published on:

  12. Engagement in the HIV care continuum combined with office-based opioid treatment remains a cornerstone in addressing the intertwined epidemics of opioid use disorder (OUD) and HIV/AIDS. Factors influencing pat...

    Authors: Babak Tofighi, Selena S. Sindhu, Chemi Chemi, Crystal Fuller Lewis, Victoria Vaughan Dickson and Joshua D. Lee

    Citation: Harm Reduction Journal 2019 16:58

    Content type: Research

    Published on:

  13. Community pharmacies are important for health access by rural populations and those who do not have optimum access to the health system, because they provide myriad health services and are found in most commun...

    Authors: Beth E. Meyerson, Carrie A. Lawrence, Summer Dawn Cope, Steven Levin, Christopher Thomas, Lori Ann Eldridge, Haley B. Coles, Nina Vadiei and Amy Kennedy

    Citation: Harm Reduction Journal 2019 16:57

    Content type: Research

    Published on:

  14. There is a dearth of evidence on injecting drug use and associated HIV and hepatitis C virus (HCV) infections in Uganda. As such, policy and programming for people who inject drugs (PWID) is limited due to sca...

    Authors: Matayo Baluku, Twaibu Wamala and Denis Muhangi

    Citation: Harm Reduction Journal 2019 16:56

    Content type: Research

    Published on:

  15. Community-based research in HIV in Canada is a complex undertaking. Including peer researchers living with HIV meaningfully is intricate and costly. However, this inclusion guarantees results that translate to...

    Authors: Francisco Ibáñez-Carrasco, James R. Watson and James Tavares

    Citation: Harm Reduction Journal 2019 16:55

    Content type: Commentary

    Published on:

  17. To identify geographic “hotspots” for potential transmission of HIV and HCV and for drug overdose among persons who use heroin and cocaine in New York City and to examine historical continuities in problem dru...

    Authors: D.C. Des Jarlais, C. McKnight, K. Arasteh, J. Feelemyer, Zev Ross and H. L. F. Cooper

    Citation: Harm Reduction Journal 2019 16:53

    Content type: Research

    Published on:

  18. Safe consumption spaces (SCS) are indoor environments in which people can use drugs with trained personnel on site to provide overdose reversal and risk reduction services. SCS have been shown to reduce fatal ...

    Authors: Allison O’Rourke, Rebecca Hamilton White, Ju Nyeong Park, Kayla Rodriguez, Michael E. Kilkenny, Susan G. Sherman and Sean T. Allen

    Citation: Harm Reduction Journal 2019 16:51

    Content type: Brief report

    Published on:

  19. There is limited literature about how to best “do” community involvement in research and no one model of community involvement in research that has been shown to be more effective than others. This paper prese...

    Authors: Melinda Walker, Kim Beadman, Steve Griffin, Mitchell Beadman and Carla Treloar

    Citation: Harm Reduction Journal 2019 16:52

    Content type: Commentary

    Published on:

  21. Ahead of opening Portugal’s first mobile drug consumption room (MDCR) in Lisbon, information from People Who Use Drugs (PWUD) and local community members was necessary to determine current needs and shape the ...

    Authors: Hannah Taylor, Adriana Curado, Joana Tavares, Miguel Oliveira, Diana Gautier and João Santa Maria

    Citation: Harm Reduction Journal 2019 16:49

    Content type: Research

    Published on:

  22. A recent study raised concerns about e-cigarette liquids toxicity by reporting the presence of 14 flavouring chemicals with toxicity classification. However, the relevant toxicity classification was not estima...

    Authors: Konstantinos Farsalinos and George Lagoumintzis

    Citation: Harm Reduction Journal 2019 16:48

    Content type: Research

    Published on:

  23. A community-based research (CBR) approach is critical to redressing the exclusion of women—particularly, traditionally marginalized women including those who use substances—from HIV research participation and ...

    Authors: Angela Kaida, Allison Carter, Valerie Nicholson, Jo Lemay, Nadia O’Brien, Saara Greene, Wangari Tharao, Karène Proulx-Boucher, Rebecca Gormley, Anita Benoit, Mélina Bernier, Jamie Thomas-Pavanel, Johanna Lewis, Alexandra de Pokomandy and Mona Loutfy

    Citation: Harm Reduction Journal 2019 16:47

    Content type: Research

    Published on:

  24. Persons in addiction treatment are likely to experience and/or witness drug overdoses following treatment and thus could benefit from overdose education and naloxone distribution (OEND) programs. Diverting ind...

    Authors: Rachel E. Gicquelais, Briana Mezuk, Betsy Foxman, Laura Thomas and Amy S. B. Bohnert

    Citation: Harm Reduction Journal 2019 16:46

    Content type: Research

    Published on:

  25. People who inject drugs (PWID) are disproportionally affected by the hepatitis C virus (HCV) infection. In the Netherlands, active HCV transmission in PWID has practically been halted but uptake of HCV testing...

    Authors: Patricia A. M. Kracht, Elisabeth A. de Gee, Agnes van der Poel, Marc A. M. T. Verhagen, Andy I. M. Hoepelman, Esther A. Croes and Joop E. Arends

    Citation: Harm Reduction Journal 2019 16:45

    Content type: Research

    Published on:

  26. Microdosing psychedelics is the practice of consuming very low, sub-hallucinogenic doses of a psychedelic substance, such as lysergic acid diethylamide (LSD) or psilocybin-containing mushrooms. According to me...

    Authors: Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory Weissman, Le-Anh Dinh-Williams, Katrina Hui and Emma Hapke

    Citation: Harm Reduction Journal 2019 16:43

    Content type: Research

    Published on:

  28. Hepatitis C Virus (HCV) infection is endemic in prison populations, and HCV management in prisons is suboptimal. Incarceration is a public health opportunity to target this cohort. Community peer support incre...

    Authors: Desmond Crowley, Ross Murtagh, Walter Cullen, Mary Keevans, Eamon Laird, Tina McHugh, Susan McKiernan, Sarah Jayne Miggin, Eileen O’Connor, Deirdre O’Reilly, Graham Betts-Symonds, Ciara Tobin, Marie Claire Van Hout and John S. Lambert

    Citation: Harm Reduction Journal 2019 16:42

    Content type: Research

    Published on:

  29. Marginalized communities often attract more than their share of research. Too often, this research benefits researchers disproportionately and leaves such communities feeling exploited, misrepresented, and exh...

    Authors: Scott D. Neufeld, Jule Chapman, Nicolas Crier, Samona Marsh, Jim McLeod and Lindsay A. Deane

    Citation: Harm Reduction Journal 2019 16:41

    Content type: Methodology

    Published on:

  30. Traditional research about substance use disorder (SUD) treatment is considered, among an increasing number of service users, to be disempowering and poorly reflective of their priorities. Thus, this methodolo...

    Authors: Henning Pettersen, Morten Brodahl, Jeanette Rundgren, Larry Davidson and Ingrid Amalia Havnes

    Citation: Harm Reduction Journal 2019 16:40

    Content type: Methodology

    Published on:

  31. Exposure to potent synthetic opioids such as illicitly manufactured fentanyl (IMF) has fueled the escalating overdose crisis in the USA, particularly in the east coast. Drug checking services, which allow peop...

    Authors: Saba Rouhani, Ju Nyeong Park, Kenneth B. Morales, Traci C. Green and Susan G. Sherman

    Citation: Harm Reduction Journal 2019 16:39

    Content type: Research

    Published on:

  32. Bacterial infection is a major cause of morbidity and mortality for persons who inject drugs (PWID). Injection cessation may help abrogate such infections, but maintaining complete cessation is challenging. Li...

    Authors: Salequl Islam, Damani A. Piggott, Alberto Moriggia, Jacquie Astemborski, Shruti H. Mehta, David L. Thomas and Gregory D. Kirk

    Citation: Harm Reduction Journal 2019 16:38

    Content type: Research

    Published on:

  33. Peer-led programs with people who use drugs (PWUD) have been a key characteristic of the harm reduction in many countries, including their involvement in research. However, peer involvement in research is ofte...

    Authors: Graham Brown, Sione Crawford, Gari-Emma Perry, Jude Byrne, James Dunne, Daniel Reeders, Angela Corry, Jane Dicka, Hunter Morgan and Sam Jones

    Citation: Harm Reduction Journal 2019 16:37

    Content type: Methodology

    Published on:

  34. Equipment used by people who inject drugs (PWID) either has a needle which is fixed to the syringe or can be detached and replaced. Detachable low dead space syringes (LDSS) have been developed, with less spac...

    Authors: Deborah Hussey, Zoe Trinder-Widdess, Cassie Dee, Darren Bagnall, Tatty Bojangles and Joanna May Kesten

    Citation: Harm Reduction Journal 2019 16:36

    Content type: Commentary

    Published on:

  35. Injecting drug use (IDU) is a key driver of the HIV epidemic particularly when individuals experience psychosocial conditions and risky sexual behavior in a syndemic manner. This study sets out to assess evide...

    Authors: Catherine Mwangi, Simon Karanja, John Gachohi, Violet Wanjihia and Zipporah Ngang’a

    Citation: Harm Reduction Journal 2019 16:35

    Content type: Research

    Published on:

  36. This study was to characterize the Methadone Maintenance Treatment (MMT) in Shanghai, China, and to explore factors associated with the decline of patients in MMT during 2005–2016.

    Authors: Lei Zhang, Jiayi Bao, Amy Harrington, Xiaoduo Fan, Zhen Ning, Jingying Zhang, Daqing Shi, Manji Hu, Zhirong Zhou, Zhengyi Cai, Min Zhao and Jiang Du

    Citation: Harm Reduction Journal 2019 16:34

    Content type: Research

    Published on:

  37. Syringe services programs (SSPs) are evidence-based interventions that are associated with decreases in prevalence and incidence rates of HIV and viral hepatitis among people who inject drugs (PWID). SSPs are ...

    Authors: Sean T. Allen, Suzanne M. Grieb, Allison O’Rourke, Ryan Yoder, Elise Planchet, Rebecca Hamilton White and Susan G. Sherman

    Citation: Harm Reduction Journal 2019 16:33

    Content type: Research

    Published on:

  38. Hepatitis C virus (HCV) infection is the leading cause of cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC) worldwide. In Europe, people who inject drugs (PWID) represent the majority of HC...

    Authors: Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz and Jeffrey V. Lazarus

    Citation: Harm Reduction Journal 2019 16:32

    Content type: Research

    Published on:

  39. Opioid substitution treatment (OST) with methadone or buprenorphine is the most effective means of treating opioid dependence. If these substances are used by people who are not undergoing OST, they can howeve...

    Authors: Björn Johnson and Torkel Richert

    Citation: Harm Reduction Journal 2019 16:31

    Content type: Research

    Published on:

  40. Supervised consumption services (SCS) are being implemented across Canada in response to a variety of drug-related harms. We explored the implementation context of newly established SCS in Toronto and the role...

    Authors: Geoff Bardwell, Carol Strike, Jason Altenberg, Lorraine Barnaby and Thomas Kerr

    Citation: Harm Reduction Journal 2019 16:30

    Content type: Research

    Published on:

  41. Hepatitis C virus (HCV) is a significant global health concern. Despite evidence of the relationship between injecting drug use and HCV, studies on HCV among people who inject drugs in developing countries rem...

    Authors: Siyan Yi, Phalkun Mun, Pheak Chhoun, Navy Chann, Sovannary Tuot and Gitau Mburu

    Citation: Harm Reduction Journal 2019 16:29

    Content type: Research

    Published on:

  42. People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OS...

    Authors: Andrew Scheibe, Katherine Young, Lorraine Moses, Rudolph L. Basson, Anna Versfeld, C. Wendy Spearman, Mark W. Sonderup, Nishi Prabdial-Sing, Jack Manamela, Adrian J. Puren, Kevin Rebe and Harry Hausler

    Citation: Harm Reduction Journal 2019 16:28

    Content type: Research

    Published on:

  43. Assessments supporting smokeless tobacco (SLT) disease risk are generally decades old. Newer epidemiological data may more accurately represent the health risks associated with contemporary US-based SLT produc...

    Authors: Michael T. Fisher, Susan Marie Tan-Torres, Charles L. Gaworski, Ryan A. Black and Mohamadi A. Sarkar

    Citation: Harm Reduction Journal 2019 16:27

    Content type: Research

    Published on:

  44. Reducing harms of youth substance use is a global priority, with parents identified as a key target for efforts to mitigate these harms. Much of the research informing parental responses to youth substance use...

    Authors: Allie Slemon, Emily K. Jenkins, Rebecca J. Haines-Saah, Zachary Daly and Sunny Jiao

    Citation: Harm Reduction Journal 2019 16:26

    Content type: Research

    Published on:

  45. Options for opioid agonist therapy (OAT) are expanding with the development of prolonged-release (also known as extended-release) 1-week, 1-month, and 6-month formulations of buprenorphine. There is an assumpt...

    Authors: Joanne Neale, Charlotte N. E. Tompkins and John Strang

    Citation: Harm Reduction Journal 2019 16:25

    Content type: Research

    Published on:

  46. The impact of gambling advertisements shown during sporting events on young people is an important public health issue. While extensive research has taken place in Australia, there is still only a limited unde...

    Authors: Natalie Djohari, Gavin Weston, Rebecca Cassidy, Martyn Wemyss and Samantha Thomas

    Citation: Harm Reduction Journal 2019 16:24

    Content type: Research

    Published on:

  47. Using a new needle for every injection can reduce the spread of infectious disease among people who inject drugs (PWID). No previous study has examined new needle use barriers among PWIDs residing in the rural...

    Authors: Stephen M. Davis, Alfgeir L. Kristjansson, Danielle Davidov, Keith Zullig, Adam Baus and Melanie Fisher

    Citation: Harm Reduction Journal 2019 16:23

    Content type: Brief report

    Published on:

  48. JUUL is the fastest growing and highest selling brand of e-cigarette/vapor products in the USA. Assessing the effect of JUUL vapor products on adult smokers’ use of conventional tobacco cigarettes can help inf...

    Authors: Christopher Russell, Farhana Haseen and Neil McKeganey

    Citation: Harm Reduction Journal 2019 16:22

    Content type: Research

    Published on:

  49. The growing HIV epidemic in Eastern Europe and Central Asia has been driven by high rates of injection drug use. The Republic of Georgia has among the highest injection drug use rates globally, with a prevalen...

    Authors: David Otiashvili, Irma Kirtadze, Irina Vardanashvili, Mzia Tabatadze and Allison J. Ober

    Citation: Harm Reduction Journal 2019 16:21

    Content type: Research

    Published on:

  50. In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-...

    Authors: Juan M. Pericàs, Daniel J. Bromberg, Denise Ocampo, Eberhard Schatz, Iwona Wawer, Piotr Wysocki, Kelly Safreed-Harmon and Jeffrey V. Lazarus

    Citation: Harm Reduction Journal 2019 16:20

    Content type: Research

    Published on:

Submit manuscript
  • ISSN: 1477-7517 (electronic)

Harm Reduction Journal

ISSN: 1477-7517